Globus Medical stockholders elect directors, approve equity plan amendment, ratify auditor, approve say-on-pay

GLOBUS MEDICAL INC

Daniel T. Scavilla elected with 249.4M votes for, 34.2M withheld; Robert A. Douglas with 281.5M for.
Amendment to 2021 Equity Incentive Plan approved: 229.9M for, 53.7M against, 58.7K abstain.
Deloitte & Touche LLP ratified as auditor for FY2023: 289.5M for, 144K against.
Non-binding advisory vote on executive compensation approved: 278.8M for, 4.9M against.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

GLOBUS MEDICAL INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-07 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 3 Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. This proposal was approved. For Against Abstain Broker Non-Vote 289,461,330 144,307 30,698 0

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

GLOBUS MEDICAL INC shareholders approved Non-binding advisory vote to approve the compensation of the Company’s named executive officers at the 2023-06-07 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 4 A non-binding advisory vote to approve the compensation of the Company’s named executive officers, as described in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission. This proposal was approved. For Against Abstain Broker Non-Vote 278,760,964 4,855,821 81,727 5,937,823

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

GLOBUS MEDICAL INC shareholders approved Election of Directors at the 2023-06-07 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 1 The individuals listed below were each elected at the Annual Meeting to serve a three-year term on the Company’s Board of Directors. Nominee For Withhold Broker Non-Vote Daniel T. Scavilla 249,448,775 34,249,737 5,937,823 Robert A. Douglas 281,453,058 2,245,454 5,937,823

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 1.0

GLOBUS MEDICAL INC shareholders approved Approval of the Amendment to the 2021 Equity Incentive Plan at the 2023-06-07 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 2 Approval of the Amendment to the 2021 Equity Incentive Plan: For Against Abstain Broker Non-Vote 229,917,089 53,722,734 58,689 5,937,823

View on SEC.gov

Browse all shareholder votes →

GLOBUS MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001562762-23-000269

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.